Biocept (BIOC) Reports Q3 Loss of $0.57/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Reddit to join S&P 500 index on Aug. 18, shares leap
- Should you chase this mini rally in gold? Citi weighs in
Feltl & Co Upgrades Biocept (BIOC) to Buy
November 10, 2016 12:55 PM ESTFeltl & Co upgraded Biocept (NASDAQ: BIOC) from Hold to Buy with a price target of $1.55.
For an analyst ratings summary and ratings history on Biocept click here. For more ratings news on Biocept click here.
Shares of Biocept closed at $0.55 yesterday.
... More